人皮肤T细胞淋巴瘤中新型磷酸化TAK1种类对NF-κB与β-catenin信号通路的功能影响
研究显示,皮肤T细胞淋巴瘤(CTCL)细胞中TAK1呈组成性激活,但受MYPT1/PP1磷酸酶复合体抑制;阻断PP1活性导致TAK1在T344、S389、T444和T511位点过度磷酸化,影响经典NF-κB信号;抑制TAK1可阻止NF-κB与β-catenin信号并诱导CTCL细胞系和原代Sézary综合征细胞凋亡。在60例原代人类样本中,T444和T344位点磷酸化TAK1的检测与淋巴瘤存在相关,并与NF-κB和β-catenin激活相关。
要点
- TAK1在CTCL细胞中组成性激活,受MYPT1/PP1磷酸酶复合体抑制。
- 阻断PP1导致TAK1在T344、S389、T444和T511位点过度磷酸化。
- 抑制TAK1可阻止NF-κB与β-catenin信号并诱导CTCL细胞凋亡。
核心结论
- TAK1是CTCL潜在的生物标志物和治疗靶点。
研究设计与样本
- 研究使用CTCL细胞系和原代Sézary综合征细胞,并在体外和体内进行实验;另检测了60例原代人类样本。
主要发现
- TAK1在CTCL细胞中组成性激活,但受MYPT1/PP1磷酸酶复合体抑制。
- 药物学和遗传学阻断PP1活性导致TAK1在T344、S389、T444和T511位点过度磷酸化,这些位点对经典NF-κB信号有功能影响。
- 抑制TAK1阻止NF-κB和β-catenin信号,并在体外和体内诱导CTCL细胞系和原代Sézary综合征细胞凋亡。
- 在60例原代人类样本中,T444和T344位点磷酸化TAK1的检测与淋巴瘤存在相关,并与NF-κB和β-catenin激活相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cutaneous T-cell lymphomas (CTCLs) represent different subtypes of lymphoproliferative disorders with no curative therapies for the advanced forms of the disease (namely mycosis fungoides and the leukemic variant, Sézary syndrome). Molecular events leading to CTCL progression are heterogeneous, however recent DNA and RNA sequencing studies highlighted the importance of NF-κB and β-catenin pathways. We here show that the kinase TAK1, known as essential in B-cell lymphoma, is constitutively activated in CTCL cells, but tempered by the MYPT1/PP1 phosphatase complex. Blocking PP1 activity, both pharmacologically and genetically, resulted in TAK1 hyperphosphorylation at residues T344, S389, T444, and T511, which have functional impact on canonical NF-κB signaling. Inhibition of TAK1 precluded NF-κB and β-catenin signaling and induced apoptosis of CTCL cell lines and primary Sézary syndrome cells both in vitro and in vivo. Detection of phosphorylated TAK1 at T444 and T344 is associated with the presence of lymphoma in a set of 60 primary human samples correlating with NF-κB and β-catenin activation. These results identified TAK1 as a potential biomarker and therapeutic target for CTCL therapy.
引用
- Gallardo F, Bertran J, López-Arribillaga E, et al. Novel phosphorylated TAK1 species with functional impact on NF-κB and β-catenin signaling in human Cutaneous T-cell lymphoma. Leukemia. 2018. PMID: 29511289. doi:10.1038/s41375-018-0066-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。